Phenotype measures set:   Crowley1   haloperidol

ID, description, units MPD:39403   haloperidol   plasma haloperidol concentration   [nM]
haloperidol study
Measures • day:    • 30    • 60    • 90    • 120
Data set, strains Crowley1   inbred w/CC8   27 strains     sex: m     age: 9-28wks
Procedure drug and metabolite quantification
Comparisontimecourse, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Crowley1 - plasma haloperidol concentration





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
between   strain 25 26205.1754 1048.207 12.0195 < 0.0001
between   Residuals 122 10639.5139 87.2091
within   day 3 40856.2288 13618.7429 892.4468 < 0.0001
within   day:strain 75 9316.2245 124.2163 8.14 < 0.0001
within   Residuals 366 5585.1617 15.26

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Crowley1 39403 drug and metabolite quantification haloperidol plasma haloperidol concentration   [nM]   on day 30   haloperidol_d30 inbred w/CC8 27 m 9-28wks
Crowley1 39404 drug and metabolite quantification haloperidol plasma haloperidol concentration   [nM]   on day 60   haloperidol_d60 inbred w/CC8 27 m 9-28wks
Crowley1 39405 drug and metabolite quantification haloperidol plasma haloperidol concentration   [nM]   on day 90   haloperidol_d90 inbred w/CC8 26 m 9-28wks
Crowley1 39406 drug and metabolite quantification haloperidol plasma haloperidol concentration   [nM]   on day 120   haloperidol_d120 inbred w/CC8 26 m 9-28wks